{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:15:39Z","timestamp":1792610139653,"version":"4.5.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 81974460"],"award-info":[{"award-number":["No. 81974460"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100021171","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","award":["No. 2021A1515010849"],"award-info":[{"award-number":["No. 2021A1515010849"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["No. 2021M700942"],"award-info":[{"award-number":["No. 2021M700942"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      LINC00173 had been reported as a cisplatin (\n                      <jats:italic>cis<\/jats:italic>\n                      -diamminedichloroplatinum, DDP) chemotherapy-resistant inducer in small-cell lung cancer (SCLC) and lung squamous cell carcinoma (LUSC). This study aimed to display reverse data for LINC00173 as a DDP chemosensitivity-inducing factor in lung adenocarcinoma (LUAD).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>LINC00173 was screened from the Gene Expression Omnibus database (GSE43493). The expression level of LINC00173 in LUAD tissues and cell lines was detected using in situ hybridization and quantitative reverse transcription\u2013polymerase chain reaction. Colony formation, cell viability, half-maximal inhibitory concentration, flow cytometry, and xenograft mouse model were used to evaluate the role of LINC00173 in the chemosensitivity of LUAD to DDP. The mechanism of LINC00173 in DDP resistance by mediating miR-1275\/PROCA1\/ZFP36L2 axis to impair BCL2 mRNA stability was applied, and co-immunoprecipitation, chromatin immunoprecipitation, RNA antisense purification, RNA immunoprecipitation, and luciferase reporter assays were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>LINC00173 downregulation in patients with DDP-resistant LUAD was correlated with poor prognosis. Further, LINC00173 expression was significantly reduced in DDP-resistant LUAD cells and DDP-treated human LUAD tissues. Suppressed LINC00173 expression in LUAD cells enhanced DDP chemoresistance in vivo and in vitro, while restored LINC00173 expression in DDP-resistant LUAD cells markedly regained chemosensitivity to DDP. Mechanistically, DDP-resistant LUAD cells activated PI3K\/AKT signal and further elevated the c-Myc expression. The c-Myc, as an oncogenic transcriptional factor, bound to the promoter of LINC00173 and suppressed its expression. The reduced LINC00173 expression attenuated the adsorption of oncogenic miR-1275, downregulating the expression of miR-1275 target gene PROCA1. PROCA1 played a potential tumor-suppressive role inducing cell apoptosis and DDP chemosensitivity via recruiting ZFP36L2 to bind to the 3\u2032 untranslated region of BCL2, reducing the stability of BCL2 mRNA and thus activating the apoptotic signal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study demonstrated a novel and critical role of LINC00173. It was transcriptionally repressed by DDP-activated PI3K\/AKT\/c-Myc signal in LUAD, promoting DDP-acquired chemotherapeutic resistance by regulating miR-1275 to suppress PROCA1\/ZFP36L2-induced BCL2 degradation, which led to apoptotic signal reduction. These data were not consistent with the previously described role of LINC00173 in SCLC or LUSC, which suggested that LINC00173 could play fine-tuned DDP resistance roles in different pathological subtypes of lung cancer. This study demonstrated that the diminished expression of LINC00173 might serve as an indicator of DDP-acquired resistance in LUAD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-022-02560-6","type":"journal-article","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T01:02:58Z","timestamp":1673312578000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275\/PROCA1\/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma"],"prefix":"10.1186","volume":"42","author":[{"given":"Xingyu","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songqing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyang","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Xian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongquan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyi","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,10]]},"reference":[{"issue":"3","key":"2560_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca-Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"Ca-Cancer J Clin"},{"issue":"7689","key":"2560_CR2","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","volume":"553","author":"RS Herbst","year":"2018","unstructured":"Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553(7689):446\u201354. https:\/\/doi.org\/10.1038\/nature25183.","journal-title":"Nature"},{"key":"2560_CR3","doi-asserted-by":"publisher","unstructured":"Ghosh S. Cisplatin: The first metal based anticancer drug. Bioorg Chem. 2019;88. https:\/\/doi.org\/10.1016\/j.bioorg.2019.102925.","DOI":"10.1016\/j.bioorg.2019.102925"},{"issue":"10","key":"2560_CR4","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0968-0004(00)89095-7","volume":"20","author":"DB Zamble","year":"1995","unstructured":"Zamble DB, Lippard SJ. Cisplatin and DNA repair in cancer chemotherapy. Trends Biochem Sci. 1995;20(10):435\u20139. https:\/\/doi.org\/10.1016\/S0968-0004(00)89095-7.","journal-title":"Trends Biochem Sci"},{"issue":"3","key":"2560_CR5","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s12033-021-00400-0","volume":"64","author":"Z Zhu","year":"2022","unstructured":"Zhu Z, Shi Y, Gong X, Li J, Zhang M. LINC00511 Knockdown Suppresses Resistance to Cisplatin in Lung Adenocarcinoma by Interacting with miR-182-3p and BIRC5. Mol Biotechnol. 2022;64(3):252\u201362. https:\/\/doi.org\/10.1007\/s12033-021-00400-0.","journal-title":"Mol Biotechnol"},{"issue":"10","key":"2560_CR6","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1111\/cas.13764","volume":"109","author":"X Zhao","year":"2018","unstructured":"Zhao X, Li X, Zhou L, et al. LncRNA HOXA11-AS drives cisplatin resistance of human LUAD cells via modulating miR-454-3p\/Stat3. Cancer Sci. 2018;109(10):3068\u201379. https:\/\/doi.org\/10.1111\/cas.13764.","journal-title":"Cancer Sci"},{"key":"2560_CR7","doi-asserted-by":"publisher","unstructured":"Sun Y, Sun H & Qi Y et al.. Ring finger protein 6 enhances chemo-resistance by transcriptionally activating proliferating cell nuclear antigen expression and attenuating DNA damage in lung adenocarcinoma. Cancer Lett. 2022;534215609. https:\/\/doi.org\/10.1016\/j.canlet.2022.215609.","DOI":"10.1016\/j.canlet.2022.215609"},{"issue":"1","key":"2560_CR8","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s13046-021-02137-9","volume":"40","author":"K Li","year":"2021","unstructured":"Li K, Peng ZY, Gao S, et al. M6A associated TSUC7 inhibition contributed to Erlotinib resistance in lung adenocarcinoma through a notch signaling activation dependent way. J Exp Clin Cancer Res. 2021;40(1):325. https:\/\/doi.org\/10.1186\/s13046-021-02137-9.","journal-title":"J Exp Clin Cancer Res"},{"key":"2560_CR9","doi-asserted-by":"publisher","unstructured":"Shen C, Yang C, Xia B & You M. Long non-coding RNAs: Emerging regulators for chemo\/immunotherapy resistance in cancer stem cells. Cancer Lett. 2021;500244\u2013252. https:\/\/doi.org\/10.1016\/j.canlet.2020.11.010.","DOI":"10.1016\/j.canlet.2020.11.010"},{"key":"2560_CR10","doi-asserted-by":"publisher","unstructured":"Li Q, Sun H & Luo D et al.. Lnc-RP11\u2013536 K7.3\/SOX2\/HIF-1alpha signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids. J Exp Clin Cancer Res. 2021;40(1):348. https:\/\/doi.org\/10.1186\/s13046-021-02143-x.","DOI":"10.1186\/s13046-021-02143-x"},{"issue":"11","key":"2560_CR11","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1038\/nm.4424","volume":"23","author":"Y Lu","year":"2017","unstructured":"Lu Y, Zhao X, Liu Q, et al. lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt\/beta-catenin signaling. Nat Med. 2017;23(11):1331\u201341. https:\/\/doi.org\/10.1038\/nm.4424.","journal-title":"Nat Med"},{"issue":"1","key":"2560_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13046-021-01854-5","volume":"40","author":"G Shu","year":"2021","unstructured":"Shu G, Su H, Wang Z, et al. LINC00680 enhances hepatocellular carcinoma stemness behavior and chemoresistance by sponging miR-568 to upregulate AKT3. J Exp Clin Cancer Res. 2021;40(1):45. https:\/\/doi.org\/10.1186\/s13046-021-01854-5.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"2560_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13046-021-02209-w","volume":"41","author":"Z Wang","year":"2022","unstructured":"Wang Z, He J, Bach DH, et al. Induction of m(6)A methylation in adipocyte exosomal LncRNAs mediates myeloma drug resistance. J Exp Clin Cancer Res. 2022;41(1):4. https:\/\/doi.org\/10.1186\/s13046-021-02209-w.","journal-title":"J Exp Clin Cancer Res"},{"key":"2560_CR14","doi-asserted-by":"publisher","unstructured":"Chen S, Yang M & Wang C et al.. Forkhead box D1 promotes EMT and chemoresistance by upregulating lncRNA CYTOR in oral squamous cell carcinoma. Cancer Lett. 2021;50343\u201353. https:\/\/doi.org\/10.1016\/j.canlet.2020.11.046.","DOI":"10.1016\/j.canlet.2020.11.046"},{"issue":"5","key":"2560_CR15","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.ccell.2016.03.004","volume":"29","author":"L Qu","year":"2016","unstructured":"Qu L, Ding J, Chen C, et al. Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA. Cancer Cell. 2016;29(5):653\u201368. https:\/\/doi.org\/10.1016\/j.ccell.2016.03.004.","journal-title":"Cancer Cell"},{"issue":"3","key":"2560_CR16","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cell.2018.03.052","volume":"173","author":"AC Bester","year":"2018","unstructured":"Bester AC, Lee JD, Chavez A, et al. An Integrated Genome-wide CRISPRa Approach to Functionalize lncRNAs in Drug Resistance. Cell. 2018;173(3):649\u201364. https:\/\/doi.org\/10.1016\/j.cell.2018.03.052.","journal-title":"Cell"},{"key":"2560_CR17","doi-asserted-by":"publisher","unstructured":"Schwarzer A, Emmrich S & Schmidt F et al.. The non-coding RNA landscape of human hematopoiesis and leukemia. Nat Commun. 2017;8. https:\/\/doi.org\/10.1038\/s41467-017-00212-4.","DOI":"10.1038\/s41467-017-00212-4"},{"issue":"7","key":"2560_CR18","first-page":"4248","volume":"11","author":"Q Yang","year":"2019","unstructured":"Yang Q, Tang Y, Tang C, et al. Diminished LINC00173 expression induced miR-182-5p accumulation promotes cell proliferation, migration and apoptosis inhibition via AGER\/NF-kappa B pathway in non-small-cell lung cancer. Am J Transl Res. 2019;11(7):4248.","journal-title":"Am J Transl Res"},{"issue":"5","key":"2560_CR19","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.3892\/ol.2019.10124","volume":"17","author":"Z Hu","year":"2019","unstructured":"Hu Z, Yang D, Tang Y, et al. Five-long non-coding RNA risk score system for the effective prediction of gastric cancer patient survival. Oncol Lett. 2019;17(5):4474\u201386. https:\/\/doi.org\/10.3892\/ol.2019.10124.","journal-title":"Oncol Lett"},{"key":"2560_CR20","doi-asserted-by":"publisher","unstructured":"Fan H, Yuan J & Li X et al.. LncRNA LINC00173 enhances triple-negative breast cancer progression by suppressing miR-490\u20133p expression. Biomed Pharmacother. 2020;125. https:\/\/doi.org\/10.1016\/j.biopha.2020.109987.","DOI":"10.1016\/j.biopha.2020.109987"},{"issue":"2","key":"2560_CR21","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41388-019-0984-2","volume":"39","author":"F Zeng","year":"2020","unstructured":"Zeng F, Wang Q, Wang S, et al. Linc00173 promotes chemoresistance and progression of small cell lung cancer by sponging miR-218 to regulate Etk expression. Oncogene. 2020;39(2):293\u2013307. https:\/\/doi.org\/10.1038\/s41388-019-0984-2.","journal-title":"Oncogene"},{"key":"2560_CR22","doi-asserted-by":"publisher","unstructured":"Chen J, Liu A & Wang Z et al.. LINC00173.v1 promotes angiogenesis and progression of lung squamous cell carcinoma by sponging miR-511\u20135p to regulate VEGFA expression. Mol Cancer. 2020;19(1). https:\/\/doi.org\/10.1186\/s12943-020-01217-2.","DOI":"10.1186\/s12943-020-01217-2"},{"issue":"8","key":"2560_CR23","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1016\/j.ejca.2014.01.024","volume":"50","author":"F Xiao","year":"2014","unstructured":"Xiao F, Bai Y, Chen Z, et al. Downregulation of HOXA1 gene affects small cell lung cancer cell survival and chemoresistance under the regulation of miR-100. Eur J Cancer. 2014;50(8):1541\u201354. https:\/\/doi.org\/10.1016\/j.ejca.2014.01.024.","journal-title":"Eur J Cancer"},{"issue":"2","key":"2560_CR24","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ccell.2018.06.012","volume":"34","author":"L Jin","year":"2018","unstructured":"Jin L, Chun J, Pan C, et al. MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEK Activation. Cancer Cell. 2018;34(2):315. https:\/\/doi.org\/10.1016\/j.ccell.2018.06.012.","journal-title":"Cancer Cell"},{"key":"2560_CR25","doi-asserted-by":"publisher","unstructured":"Friedrich T, Soehn M & Gutting T et al.. Subcellular compartmentalization of docking protein-1 contributes to progression in colorectal cancer. Ebiomedicine. 2016;8159\u2013172. https:\/\/doi.org\/10.1016\/j.ebiom.2016.05.003.","DOI":"10.1016\/j.ebiom.2016.05.003"},{"issue":"1","key":"2560_CR26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.cellsig.2014.10.010","volume":"27","author":"MY Zemskova","year":"2015","unstructured":"Zemskova MY, Song JH, Cen B, et al. Regulation of prostate stromal fibroblasts by the PIM1 protein kinase. Cell Signal. 2015;27(1):135\u201346. https:\/\/doi.org\/10.1016\/j.cellsig.2014.10.010.","journal-title":"Cell Signal"},{"key":"2560_CR27","doi-asserted-by":"publisher","unstructured":"Zhen Y, Liu Z & Yang H et al.. Tumor suppressor PDCD4 modulates miR-184-mediated direct suppression of C-MYC and BCL2 blocking cell growth and survival in nasopharyngeal carcinoma. Cell Death Dis. 2013;4. https:\/\/doi.org\/10.1038\/cddis.2013.376.","DOI":"10.1038\/cddis.2013.376"},{"key":"2560_CR28","doi-asserted-by":"publisher","unstructured":"Xu M, Chen X & Lin K et al.. lncRNA SNHG6 regulates EZH2 expression by sponging miR-26a\/b and miR-214 in colorectal cancer. J Hematol Oncol. 2019;12. https:\/\/doi.org\/10.1186\/s13045-018-0690-5.","DOI":"10.1186\/s13045-018-0690-5"},{"key":"2560_CR29","doi-asserted-by":"publisher","unstructured":"Qu W, Huang W, Yang F, Ju H & Zhu G. Long noncoding RNA LINC00461 mediates cisplatin resistance of rectal cancer via miR-593\u20135p\/CCND1 axis. Biomed Pharmacother. 2020;124109740. https:\/\/doi.org\/10.1016\/j.biopha.2019.109740.","DOI":"10.1016\/j.biopha.2019.109740"},{"issue":"3","key":"2560_CR30","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/nsmb738","volume":"11","author":"BP Hudson","year":"2004","unstructured":"Hudson BP, Martinez-Yamout MA, Dyson HJ, Wright PE. Recognition of the mRNA AU-rich element by the zinc finger domain of TIS11d. Nat Struct Mol Biol. 2004;11(3):257\u201364. https:\/\/doi.org\/10.1038\/nsmb738.","journal-title":"Nat Struct Mol Biol"},{"issue":"15","key":"2560_CR31","doi-asserted-by":"publisher","first-page":"10037","DOI":"10.1093\/nar\/gku652","volume":"42","author":"S Adachi","year":"2014","unstructured":"Adachi S, Homoto M, Tanaka R, et al. ZFP36L1 and ZFP36L2 control LDLR mRNA stability via the ERK-RSK pathway. Nucleic Acids Res. 2014;42(15):10037\u201349. https:\/\/doi.org\/10.1093\/nar\/gku652.","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"2560_CR32","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1158\/0008-5472.CAN-07-5723","volume":"68","author":"S Soundararajan","year":"2008","unstructured":"Soundararajan S, Chen W, Spicer EK, Courtenay-Luck N, Fernandes DJ. The nucleolin targeting aptamer AS1411 destabilizes bcl-2 messenger RNA in human breast cancer cells. Cancer Res. 2008;68(7):2358\u201365. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-5723.","journal-title":"Cancer Res"},{"issue":"6478","key":"2560_CR33","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/369321a0","volume":"369","author":"XM Yin","year":"1994","unstructured":"Yin XM, Oltvai ZN, Korsmeyer SJ. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature. 1994;369(6478):321\u20133. https:\/\/doi.org\/10.1038\/369321a0.","journal-title":"Nature"},{"issue":"25","key":"2560_CR34","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1182\/blood-2016-01-688796","volume":"127","author":"MA Anderson","year":"2016","unstructured":"Anderson MA, Deng J, Seymour JF, et al. The BCL2 selective inhibitor venetoclax induces rapid onset apoptosis of CLL cells in patients via a TP53-independent mechanism. Blood. 2016;127(25):3215\u201324. https:\/\/doi.org\/10.1182\/blood-2016-01-688796.","journal-title":"Blood"},{"key":"2560_CR35","doi-asserted-by":"publisher","unstructured":"Liu C, Peng X & Li Y et al.. Positive feedback loop of FAM83A\/PI3K\/AKT\/c-Jun induces migration, invasion and metastasis in hepatocellular carcinoma. Biomed Pharmacother. 2020;123. https:\/\/doi.org\/10.1016\/j.biopha.2019.109780.","DOI":"10.1016\/j.biopha.2019.109780"},{"key":"2560_CR36","doi-asserted-by":"publisher","unstructured":"Li Y, Liu X & Lin X et al.. Chemical compound cinobufotalin potently induces FOXO1-stimulated cisplatin sensitivity by antagonizing its binding partner MYH9. SIGNAL TRANSDUCTION AND TARGETED THERAPY. 2019;4. https:\/\/doi.org\/10.1038\/s41392-019-0084-3.","DOI":"10.1038\/s41392-019-0084-3"},{"key":"2560_CR37","doi-asserted-by":"publisher","unstructured":"Li R, Liu J, Fang Z, Liang Z & Chen X. Identification of Mutations Related to Cisplatin-Resistance and Prognosis of Patients With Lung Adenocarcinoma. Front Pharmacol. 2020;11. https:\/\/doi.org\/10.3389\/fphar.2020.572627.","DOI":"10.3389\/fphar.2020.572627"},{"issue":"5","key":"2560_CR38","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/joim.13201","volume":"289","author":"DAJ Sainz","year":"2021","unstructured":"Sainz DAJ, Dost A, Kim CF. Alveolar progenitor cells and the origin of lung cancer. J Intern Med. 2021;289(5):629\u201335. https:\/\/doi.org\/10.1111\/joim.13201.","journal-title":"J Intern Med"},{"issue":"16","key":"2560_CR39","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.4161\/cc.10.16.17012","volume":"10","author":"KS Park","year":"2011","unstructured":"Park KS, Liang MC, Raiser DM, et al. Characterization of the cell of origin for small cell lung cancer. Cell Cycle. 2011;10(16):2806\u201315. https:\/\/doi.org\/10.4161\/cc.10.16.17012.","journal-title":"Cell Cycle"},{"issue":"6","key":"2560_CR40","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.ccr.2011.04.019","volume":"19","author":"KD Sutherland","year":"2011","unstructured":"Sutherland KD, Proost N, Brouns I, et al. Cell of origin of small cell lung cancer: inactivation of Trp53 and Rb1 in distinct cell types of adult mouse lung. Cancer Cell. 2011;19(6):754\u201364. https:\/\/doi.org\/10.1016\/j.ccr.2011.04.019.","journal-title":"Cancer Cell"},{"key":"2560_CR41","volume-title":"WHO Classification of Tumours of the Lung, Plura, Thymus and Heart","author":"WH Organization","year":"2014","unstructured":"Organization WH. WHO Classification of Tumours of the Lung, Plura, Thymus and Heart. 2014."},{"issue":"13","key":"2560_CR42","doi-asserted-by":"publisher","first-page":"4910","DOI":"10.1073\/pnas.1112499109","volume":"109","author":"X Xu","year":"2012","unstructured":"Xu X, Rock JR, Lu Y, et al. Evidence for type II cells as cells of origin of K-Ras-induced distal lung adenocarcinoma. Proc Natl Acad Sci U S A. 2012;109(13):4910\u20135. https:\/\/doi.org\/10.1073\/pnas.1112499109.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2560_CR43","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.7150\/ijbs.41230","volume":"16","author":"W Lu","year":"2020","unstructured":"Lu W, Yang C, He H, Liu H. The CARM1-p300-c-Myc-Max (CPCM) transcriptional complex regulates the expression of CUL4A\/4B and affects the stability of CRL4 E3 ligases in colorectal cancer. Int J Biol Sci. 2020;16(6):1071\u201385. https:\/\/doi.org\/10.7150\/ijbs.41230.","journal-title":"Int J Biol Sci"},{"issue":"4","key":"2560_CR44","doi-asserted-by":"publisher","first-page":"2002746","DOI":"10.1002\/advs.202002746","volume":"8","author":"F Sun","year":"2021","unstructured":"Sun F, Zhu Q, Li T, et al. Regulating Glucose Metabolism with Prodrug Nanoparticles for Promoting Photoimmunotherapy of Pancreatic Cancer. Adv Sci (Weinh). 2021;8(4):2002746. https:\/\/doi.org\/10.1002\/advs.202002746.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"2560_CR45","doi-asserted-by":"publisher","first-page":"178","DOI":"10.7150\/ijbs.51458","volume":"17","author":"Y Liu","year":"2021","unstructured":"Liu Y, Zhu C, Tang L, et al. MYC dysfunction modulates stemness and tumorigenesis in breast cancer. Int J Biol Sci. 2021;17(1):178\u201387. https:\/\/doi.org\/10.7150\/ijbs.51458.","journal-title":"Int J Biol Sci"},{"key":"2560_CR46","doi-asserted-by":"publisher","unstructured":"He J, Li F & Zhou Y et al.. LncRNA XLOC_006390 promotes pancreatic carcinogenesis and glutamate metabolism by stabilizing c-Myc. Cancer Lett. 2020;469419\u2013428. https:\/\/doi.org\/10.1016\/j.canlet.2019.11.021.","DOI":"10.1016\/j.canlet.2019.11.021"},{"key":"2560_CR47","doi-asserted-by":"publisher","unstructured":"Wang L, Zhang Z & Yu X et al.. SOX9\/miR-203a axis drives PI3K\/AKT signaling to promote esophageal cancer progression. Cancer Lett. 2020;46814\u201326. https:\/\/doi.org\/10.1016\/j.canlet.2019.10.004.","DOI":"10.1016\/j.canlet.2019.10.004"},{"issue":"15","key":"2560_CR48","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.7150\/ijbs.47051","volume":"16","author":"G Liu","year":"2020","unstructured":"Liu G, Guo W, Chen G, et al. Lnc-MCEI mediated the chemosensitivity of esophageal squamous cell carcinoma via miR-6759-5p to competitively regulate IGF2. Int J Biol Sci. 2020;16(15):2938\u201350. https:\/\/doi.org\/10.7150\/ijbs.47051.","journal-title":"Int J Biol Sci"},{"issue":"2","key":"2560_CR49","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1159\/000480473","volume":"43","author":"R Zhang","year":"2017","unstructured":"Zhang R, Sun S, Ji F, et al. CNTN-1 Enhances Chemoresistance in Human Lung Adenocarcinoma Through Induction of Epithelial-Mesenchymal Transition by Targeting the PI3K\/Akt Pathway. Cell Physiol Biochem. 2017;43(2):465\u201380. https:\/\/doi.org\/10.1159\/000480473.","journal-title":"Cell Physiol Biochem"},{"key":"2560_CR50","doi-asserted-by":"publisher","unstructured":"Qian J, LeSavage B L & Hubka K M et al.. Cancer-associated mesothelial cells promote ovarian cancer chemoresistance through paracrine osteopontin signaling. J Clin Invest. 2021;131(16). https:\/\/doi.org\/10.1172\/JCI146186.","DOI":"10.1172\/JCI146186"},{"issue":"6","key":"2560_CR51","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1002\/med.21573","volume":"39","author":"M Wiese","year":"2019","unstructured":"Wiese M, Stefan YM. The A-B-C of small-molecule ABC transport protein modulators: From inhibition to activation-a case study of multidrug resistance-associated protein 1 (ABCC1). Med Res Rev. 2019;39(6):2031\u201381. https:\/\/doi.org\/10.1002\/med.21573.","journal-title":"Med Res Rev"},{"key":"2560_CR52","doi-asserted-by":"publisher","unstructured":"Reily Rocha C R, Silva M M, Quinet A, Cabral-Neto J B & Martins Menck C F. DNA repair pathways and cisplatin resistance: an intimate relationship. Clinics. 2018;731. https:\/\/doi.org\/10.6061\/clinics\/2018\/e478s.","DOI":"10.6061\/clinics\/2018\/e478s"},{"issue":"3","key":"2560_CR53","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1124\/pr.111.005637","volume":"64","author":"D Shen","year":"2012","unstructured":"Shen D, Pouliot LM, Hall MD, Gottesman MM. Cisplatin Resistance: A Cellular Self-Defense Mechanism Resulting from Multiple Epigenetic and Genetic Changes. Pharmacol Rev. 2012;64(3):706\u201321. https:\/\/doi.org\/10.1124\/pr.111.005637.","journal-title":"Pharmacol Rev"},{"issue":"9","key":"2560_CR54","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/s41401-019-0340-7","volume":"41","author":"XL Zheng","year":"2020","unstructured":"Zheng XL, Yang JJ, Wang YY, et al. RIP1 promotes proliferation through G2\/M checkpoint progression and mediates cisplatin-induced apoptosis and necroptosis in human ovarian cancer cells. Acta Pharmacol Sin. 2020;41(9):1223\u201333. https:\/\/doi.org\/10.1038\/s41401-019-0340-7.","journal-title":"Acta Pharmacol Sin"},{"issue":"12","key":"2560_CR55","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1038\/s41388-022-02200-5","volume":"41","author":"G Ma","year":"2022","unstructured":"Ma G, Deng Y, Qian L, et al. Overcoming acquired resistance to third-generation EGFR inhibitors by targeting activation of intrinsic apoptotic pathway through Mcl-1 inhibition, Bax activation, or both. Oncogene. 2022;41(12):1691\u2013700. https:\/\/doi.org\/10.1038\/s41388-022-02200-5.","journal-title":"Oncogene"},{"key":"2560_CR56","doi-asserted-by":"publisher","unstructured":"Li M, Zhang Y, Shang J, Xu Y. LncRNA SNHG5 promotes cisplatin resistance in gastric cancer via inhibiting cell apoptosis. Eur Rev Med Pharmaco. 2019;23(10):4185\u201391. https:\/\/doi.org\/10.26355\/eurrev_201905_17921.","DOI":"10.26355\/eurrev_201905_17921"},{"issue":"1","key":"2560_CR57","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13046-020-01613-y","volume":"39","author":"M Yu","year":"2020","unstructured":"Yu M, Ozaki T, Sun D, et al. HIF-1alpha-dependent miR-424 induction confers cisplatin resistance on bladder cancer cells through down-regulation of pro-apoptotic UNC5B and SIRT4. J Exp Clin Cancer Res. 2020;39(1):108. https:\/\/doi.org\/10.1186\/s13046-020-01613-y.","journal-title":"J Exp Clin Cancer Res"},{"key":"2560_CR58","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021014304","author":"D Thomalla","year":"2022","unstructured":"Thomalla D, Beckmann L, Grimm C, et al. Deregulation and epigenetic modification of BCL2-family genes cause resistance to venetoclax in hematologic malignancies. Blood. 2022. https:\/\/doi.org\/10.1182\/blood.2021014304.","journal-title":"Blood"},{"issue":"1","key":"2560_CR59","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrm2308","volume":"9","author":"RJ Youle","year":"2008","unstructured":"Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Bio. 2008;9(1):47\u201359. https:\/\/doi.org\/10.1038\/nrm2308.","journal-title":"Nat Rev Mol Cell Bio"},{"key":"2560_CR60","doi-asserted-by":"publisher","unstructured":"Liu L, Wang Q & Mao J et al.. Salinomycin suppresses cancer cell sternness and attenuates TGF-beta-induced epithelial-mesenchymal transition of renal cell carcinoma cells. Chem-Biol Interact. 2018;296145\u2013153. https:\/\/doi.org\/10.1016\/j.cbi.2018.09.018.","DOI":"10.1016\/j.cbi.2018.09.018"},{"issue":"1","key":"2560_CR61","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/cbf.3368","volume":"37","author":"J Shi","year":"2019","unstructured":"Shi J, Zhong X, Song Y, et al. Long non-coding RNA RUNX1-IT1 plays a tumour-suppressive role in colorectal cancer by inhibiting cell proliferation and migration. Cell Biochem Funct. 2019;37(1):11\u201320. https:\/\/doi.org\/10.1002\/cbf.3368.","journal-title":"Cell Biochem Funct"},{"issue":"6","key":"2560_CR62","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.7150\/thno.41120","volume":"10","author":"N Jiang","year":"2020","unstructured":"Jiang N, Zou C, Zhu Y, et al. HIF-1 alpha-regulated miR-1275 maintains stem cell-like phenotypes and promotes the progression of LUAD by simultaneously activating Wnt\/beta-catenin and Notch signaling. Theranostics. 2020;10(6):2553\u201370. https:\/\/doi.org\/10.7150\/thno.41120.","journal-title":"Theranostics"},{"issue":"32","key":"2560_CR63","doi-asserted-by":"publisher","first-page":"33727","DOI":"10.1074\/jbc.M401708200","volume":"279","author":"S Diederichs","year":"2004","unstructured":"Diederichs S, Baumer N, Ji P, et al. Identification of interaction partners and substrates of the cyclin A1-CDK2 complex. J Biol Chem. 2004;279(32):33727\u201341. https:\/\/doi.org\/10.1074\/jbc.M401708200.","journal-title":"J Biol Chem"},{"key":"2560_CR64","doi-asserted-by":"publisher","unstructured":"Liu J, Lu W & Liu S et al.. ZFP36L2, a novel AML1 target gene, induces AML cells apoptosis and inhibits cell proliferation. Leukemia Res. 2018;6815\u201321. https:\/\/doi.org\/10.1016\/j.leukres.2018.02.017.","DOI":"10.1016\/j.leukres.2018.02.017"},{"issue":"7","key":"2560_CR65","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s10495-010-0489-5","volume":"15","author":"C Chen","year":"2010","unstructured":"Chen C, Zhou H, Xu L, et al. Recombinant human PDCD5 sensitizes chondrosarcomas to cisplatin chemotherapy in vitro and in vivo. Apoptosis. 2010;15(7):805\u201313. https:\/\/doi.org\/10.1007\/s10495-010-0489-5.","journal-title":"Apoptosis"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-022-02560-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-022-02560-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-022-02560-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T10:29:15Z","timestamp":1673605755000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-022-02560-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,10]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2560"],"URL":"https:\/\/doi.org\/10.1186\/s13046-022-02560-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1518812\/v1","asserted-by":"object"}]},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,10]]},"assertion":[{"value":"5 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of Guangzhou Medical University. The informed consent was obtained from each participant. All animal experiments were approved by Animal Care and Use Committee of Guangzhou Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to submit the article for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author declares no competing interest exists.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}